Intra-Cellular Therapies, Inc.

ITCI · NASDAQ
Analyze with AI
12/31/2024
9/30/2024
6/30/2024
3/31/2024
Assets
Cash & Equivalents$306,948$464,312$695,056$141,569
Short-Term Investments$694,118$542,250$329,601$335,804
Receivables$166,500$145,608$145,714$131,157
Inventory$26,283$23,539$20,082$15,949
Other Curr. Assets$113,515$96,022$75,548$67,798
Total Curr. Assets$1,307,364$1,271,731$1,264,251$690,527
Property Plant & Equip (Net)$14,896$16,016$15,952$14,003
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$44,652$36,698$40,301$42,506
Total NC Assets$59,548$52,714$56,253$56,509
Other Assets$0$0$0$0
Total Assets$1,366,912$1,324,445$1,320,504$747,036
Liabilities
Payables$26,074$10,338$17,548$11,532
Short-Term Debt$4,233$8,406$8,342$3,639
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$175,397$147,369$135,885$119,630
Total Curr. Liab.$205,704$166,113$161,775$134,801
LT Debt$12,748$13,506$14,117$12,737
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$0
Total NC Liab.$12,748$13,506$14,117$12,737
Other Liabilities$0$0$0$0
Cap. Leases$16,981$17,709$18,288$16,376
Total Liabilities$218,452$179,619$175,892$147,538
Equity
Pref Stock$0$0$0$0
Common Stock$11$11$11$10
Retained Earnings-$1,691,836-$1,674,951-$1,648,627-$1,632,407
AOCI$191$1,629-$668-$430
Other Equity$2,840,094$2,818,137$2,793,896$2,232,325
Total Equity$1,148,460$1,144,826$1,144,612$599,498
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$1,366,912$1,324,445$1,320,504$747,036
Net Debt-$289,967-$442,400-$672,597-$125,193
Intra-Cellular Therapies, Inc. (ITCI) Financial Statements & Key Stats | AlphaPilot